Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN

The stoppage of nucleoside analog (NA) can lead to immune flare and loss of HBsAg in a proportion of HBeAg-negative chronic hepatitis B (CHB) patients. HBsAg loss could be improved by instituting Peg-Interferon therapy in those who show an immune flare after the stoppage of NA. We investigated the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Mojahidul, Kumar, Karan, Sevak, Jayesh K., Jindal, Ankur, Vyas, Ashish K., Ramakrishna, Gayatri, Kottilil, Shyamasundaran, Sharma, Manoj K., Sarin, Shiv K., Trehanpati, Nirupama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145869/
https://www.ncbi.nlm.nih.gov/pubmed/37102765
http://dx.doi.org/10.1097/HC9.0000000000000098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145869/
https://www.ncbi.nlm.nih.gov/pubmed/37102765
http://dx.doi.org/10.1097/HC9.0000000000000098

Ejemplares similares